Monotitan Tablets 80 mg (Telmisartan)

Adult dose

Take 40 mg orally once daily with water, and can be taken regardless of meals. In some patients, 20 mg once daily may be effective, and if necessary, it may be increased to 80 mg once daily. For the purpose of reducing cardiovascular disease risk, an oral dose of 80 mg once daily is recommended. Patients with liver impairment should not exceed 40 mg daily.

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients with known allergies to this drug or its ingredients, in pregnant or nursing women, in patients with severe liver or biliary disease, in patients with a history of hereditary angioedema, or in patients with diabetes or severe renal impairment. This drug should be used with caution in the elderly, patients with high serum potassium levels, patients with impaired liver function, and in patients with heart valve disease or cerebrovascular disorders, as there is a risk of excessively low blood pressure leading to problems in the heart or brain. When taking this medication, watch for symptom changes as side effects such as infections, blood pressure drops, liver function abnormalities, renal function deterioration, angioedema, and hyperkalemia may occur. Particularly, diabetic patients should be alert to symptoms of hypoglycemia, and if swelling of the face or lips occurs, they should stop taking the drug immediately and seek medical attention. Patients with renal impairment should often monitor potassium and creatinine levels through blood tests, as low blood volume or salt deficiency may lead to symptoms of low blood pressure, thus caution is required. There may be interactions when taken with other antihypertensives, diuretics, lithium, non-steroidal anti-inflammatory drugs, so consultation with a physician or pharmacist is necessary. Pregnant or nursing women should ideally not take this medication, and if unavoidable, should consult a specialist and discontinue breastfeeding. Use in children under 18 years is not recommended as safety and efficacy have not been established. In case of overdose, symptoms such as low blood pressure, dizziness, and renal impairment may occur, so immediate treatment in a hospital is required, noting that this drug cannot be removed by dialysis. This medication should be kept out of reach of children, and transferring it to another container should be avoided to reduce the risk of accidents or degradation of quality. Caution is advised as dizziness or fainting may occur while driving or operating dangerous machinery during treatment.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, sepsis (including fatal outcomes), anaphylactic reactions, angioedema (including fatal outcomes), angioedema-related laryngeal edema, respiratory distress, liver dysfunction/liver impairment, liver failure, jaundice, severe hyperkalemia, acute renal failure, acute kidney injury including kidney impairment, shock, fainting due to reduced blood pressure, loss of consciousness, interstitial lung disease,

Mild side effects

• Upper respiratory tract infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly sealed container to prevent air or moisture exposure, at a temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be safely maintained.

Appearance

White oval tablets

Package unit

30 tablets/bottle